| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 64 | 2024 | 474 | 9.510 |
Why?
|
| Genetic Predisposition to Disease | 30 | 2024 | 677 | 3.780 |
Why?
|
| Mutation | 40 | 2024 | 2427 | 3.010 |
Why?
|
| Profilins | 8 | 2024 | 45 | 1.650 |
Why?
|
| Frontotemporal Dementia | 11 | 2024 | 126 | 1.640 |
Why?
|
| Genome-Wide Association Study | 16 | 2022 | 324 | 1.490 |
Why?
|
| RNA-Binding Protein FUS | 7 | 2021 | 50 | 1.240 |
Why?
|
| Exome | 7 | 2024 | 73 | 1.110 |
Why?
|
| Parkinson Disease | 2 | 2024 | 97 | 1.040 |
Why?
|
| Motor Neurons | 11 | 2023 | 206 | 0.960 |
Why?
|
| Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 | 1 | 2024 | 6 | 0.930 |
Why?
|
| Polymorphism, Single Nucleotide | 17 | 2021 | 462 | 0.890 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2024 | 79 | 0.880 |
Why?
|
| Genetic Association Studies | 9 | 2018 | 120 | 0.870 |
Why?
|
| Glaucoma, Open-Angle | 5 | 2017 | 42 | 0.840 |
Why?
|
| Lewy Body Disease | 1 | 2022 | 7 | 0.830 |
Why?
|
| DNA Repeat Expansion | 5 | 2024 | 53 | 0.680 |
Why?
|
| Humans | 79 | 2024 | 59350 | 0.670 |
Why?
|
| C9orf72 Protein | 10 | 2024 | 98 | 0.660 |
Why?
|
| Aryldialkylphosphatase | 2 | 2010 | 19 | 0.660 |
Why?
|
| Loss of Function Mutation | 2 | 2021 | 20 | 0.650 |
Why?
|
| NIMA-Related Kinase 1 | 2 | 2023 | 4 | 0.600 |
Why?
|
| Neurons | 9 | 2021 | 858 | 0.590 |
Why?
|
| Tubulin | 2 | 2015 | 74 | 0.580 |
Why?
|
| Case-Control Studies | 12 | 2024 | 1061 | 0.550 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2024 | 135 | 0.550 |
Why?
|
| Cytoskeletal Proteins | 6 | 2020 | 194 | 0.510 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2014 | 2 | 0.480 |
Why?
|
| Exfoliation Syndrome | 1 | 2014 | 5 | 0.470 |
Why?
|
| Pedigree | 7 | 2024 | 190 | 0.470 |
Why?
|
| Amino Acid Sequence | 7 | 2021 | 1582 | 0.460 |
Why?
|
| Phenotype | 7 | 2022 | 1157 | 0.460 |
Why?
|
| Proteins | 6 | 2023 | 742 | 0.440 |
Why?
|
| Glaucoma | 3 | 2020 | 48 | 0.430 |
Why?
|
| Neurodegenerative Diseases | 3 | 2024 | 127 | 0.410 |
Why?
|
| Cohort Studies | 13 | 2021 | 2437 | 0.410 |
Why?
|
| Mutant Proteins | 1 | 2012 | 105 | 0.400 |
Why?
|
| Sequence Analysis, RNA | 1 | 2013 | 152 | 0.390 |
Why?
|
| Actins | 4 | 2019 | 260 | 0.390 |
Why?
|
| Male | 33 | 2024 | 27526 | 0.380 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2019 | 87 | 0.370 |
Why?
|
| Female | 34 | 2024 | 30845 | 0.360 |
Why?
|
| Drosophila | 6 | 2021 | 419 | 0.360 |
Why?
|
| Esterases | 1 | 2010 | 13 | 0.360 |
Why?
|
| Haplotypes | 3 | 2012 | 117 | 0.350 |
Why?
|
| Genetic Testing | 5 | 2023 | 133 | 0.340 |
Why?
|
| Intraocular Pressure | 4 | 2020 | 61 | 0.340 |
Why?
|
| Axonal Transport | 2 | 2022 | 31 | 0.340 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 659 | 0.320 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2015 | 416 | 0.320 |
Why?
|
| Active Transport, Cell Nucleus | 4 | 2023 | 106 | 0.310 |
Why?
|
| Middle Aged | 19 | 2024 | 16254 | 0.290 |
Why?
|
| Aged | 17 | 2024 | 13308 | 0.290 |
Why?
|
| Drug Delivery Systems | 1 | 2010 | 307 | 0.280 |
Why?
|
| Axons | 3 | 2020 | 120 | 0.280 |
Why?
|
| SMN Complex Proteins | 2 | 2021 | 5 | 0.280 |
Why?
|
| Membrane Proteins | 3 | 2019 | 843 | 0.280 |
Why?
|
| Animals | 20 | 2021 | 19618 | 0.270 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 5071 | 0.260 |
Why?
|
| Genotype | 8 | 2019 | 644 | 0.260 |
Why?
|
| DNA-Binding Proteins | 6 | 2020 | 1128 | 0.250 |
Why?
|
| Mutation, Missense | 4 | 2024 | 179 | 0.250 |
Why?
|
| Sequence Analysis, DNA | 5 | 2016 | 396 | 0.250 |
Why?
|
| Australia | 5 | 2020 | 93 | 0.240 |
Why?
|
| Drug Repositioning | 1 | 2024 | 6 | 0.240 |
Why?
|
| Microfilament Proteins | 3 | 2019 | 116 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 4 | 2015 | 421 | 0.230 |
Why?
|
| Neurofilament Proteins | 1 | 2024 | 16 | 0.230 |
Why?
|
| Superoxide Dismutase | 3 | 2022 | 213 | 0.230 |
Why?
|
| Exons | 4 | 2019 | 193 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2065 | 0.210 |
Why?
|
| Ataxin-2 | 1 | 2022 | 4 | 0.210 |
Why?
|
| Golgi Apparatus | 2 | 2019 | 64 | 0.200 |
Why?
|
| Gain of Function Mutation | 1 | 2022 | 13 | 0.200 |
Why?
|
| Mice | 11 | 2020 | 10260 | 0.200 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2021 | 15 | 0.190 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2021 | 20 | 0.190 |
Why?
|
| Quantitative Trait Loci | 3 | 2021 | 72 | 0.190 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2021 | 26 | 0.190 |
Why?
|
| Superoxide Dismutase-1 | 5 | 2023 | 134 | 0.190 |
Why?
|
| Neuroprotective Agents | 2 | 2024 | 73 | 0.180 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2021 | 7 | 0.180 |
Why?
|
| Gene Expression | 3 | 2019 | 808 | 0.180 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 35 | 0.180 |
Why?
|
| Young Adult | 8 | 2021 | 4321 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2010 | 10 | 0.180 |
Why?
|
| Deubiquitinating Enzyme CYLD | 1 | 2020 | 2 | 0.170 |
Why?
|
| Alleles | 4 | 2021 | 425 | 0.170 |
Why?
|
| Thiazoles | 2 | 2019 | 47 | 0.170 |
Why?
|
| Neuropathology | 1 | 2019 | 3 | 0.170 |
Why?
|
| DNA Copy Number Variations | 2 | 2010 | 65 | 0.170 |
Why?
|
| Huntingtin Protein | 1 | 2020 | 138 | 0.170 |
Why?
|
| Netherlands | 2 | 2016 | 24 | 0.170 |
Why?
|
| Antigens, Ly | 1 | 2019 | 40 | 0.170 |
Why?
|
| Nuclear Pore | 1 | 2019 | 22 | 0.170 |
Why?
|
| Whole Genome Sequencing | 4 | 2021 | 61 | 0.160 |
Why?
|
| Myosin Heavy Chains | 1 | 2019 | 40 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 82 | 0.160 |
Why?
|
| Glycosyltransferases | 1 | 2019 | 9 | 0.160 |
Why?
|
| Homeostasis | 2 | 2023 | 340 | 0.160 |
Why?
|
| Histone Acetyltransferases | 2 | 2010 | 56 | 0.160 |
Why?
|
| Receptors, AMPA | 1 | 2019 | 41 | 0.160 |
Why?
|
| Adult | 13 | 2021 | 15746 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2019 | 98 | 0.160 |
Why?
|
| Cell Line | 6 | 2019 | 2014 | 0.150 |
Why?
|
| Genotyping Techniques | 2 | 2016 | 14 | 0.150 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 167 | 0.150 |
Why?
|
| T-Cell Intracellular Antigen-1 | 1 | 2017 | 1 | 0.150 |
Why?
|
| Wallerian Degeneration | 1 | 2018 | 8 | 0.150 |
Why?
|
| Transduction, Genetic | 1 | 2019 | 233 | 0.150 |
Why?
|
| Central Nervous System | 1 | 2019 | 191 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2016 | 357 | 0.140 |
Why?
|
| Annexins | 1 | 2017 | 9 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 630 | 0.140 |
Why?
|
| Stress, Physiological | 1 | 2019 | 185 | 0.140 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 293 | 0.140 |
Why?
|
| Schizophrenia | 1 | 2019 | 256 | 0.140 |
Why?
|
| Organogenesis | 1 | 2017 | 40 | 0.140 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1470 | 0.140 |
Why?
|
| Sirtuin 2 | 1 | 2016 | 6 | 0.140 |
Why?
|
| Munc18 Proteins | 1 | 2016 | 12 | 0.140 |
Why?
|
| Myelin Proteins | 1 | 2016 | 30 | 0.140 |
Why?
|
| Neuromuscular Junction | 1 | 2017 | 82 | 0.130 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 125 | 0.130 |
Why?
|
| Unfolded Protein Response | 1 | 2017 | 53 | 0.130 |
Why?
|
| Eye Proteins | 2 | 2020 | 73 | 0.130 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2016 | 22 | 0.130 |
Why?
|
| Cyclins | 1 | 2016 | 40 | 0.130 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 384 | 0.130 |
Why?
|
| HEK293 Cells | 2 | 2021 | 577 | 0.130 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 85 | 0.130 |
Why?
|
| Drosophila Proteins | 2 | 2019 | 681 | 0.130 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 697 | 0.130 |
Why?
|
| Disease Progression | 5 | 2021 | 1040 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 1537 | 0.130 |
Why?
|
| Calcium | 1 | 2019 | 555 | 0.130 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2015 | 4 | 0.130 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 759 | 0.130 |
Why?
|
| Scotoma | 1 | 2015 | 6 | 0.130 |
Why?
|
| Cell Nucleus | 1 | 2019 | 603 | 0.120 |
Why?
|
| Age of Onset | 2 | 2012 | 173 | 0.120 |
Why?
|
| Visual Fields | 1 | 2015 | 42 | 0.120 |
Why?
|
| Glycoproteins | 2 | 2020 | 193 | 0.120 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2015 | 15 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 250 | 0.120 |
Why?
|
| Meta-Analysis as Topic | 4 | 2018 | 77 | 0.120 |
Why?
|
| Scanning Laser Polarimetry | 1 | 2014 | 1 | 0.120 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2014 | 10 | 0.120 |
Why?
|
| Hydro-Lyases | 1 | 2014 | 8 | 0.120 |
Why?
|
| Ocular Hypertension | 1 | 2014 | 7 | 0.120 |
Why?
|
| Tonometry, Ocular | 1 | 2014 | 15 | 0.120 |
Why?
|
| Huntington Disease | 1 | 2016 | 146 | 0.120 |
Why?
|
| Animals, Genetically Modified | 3 | 2021 | 281 | 0.120 |
Why?
|
| Brain | 3 | 2021 | 1489 | 0.120 |
Why?
|
| Cell Membrane | 1 | 2017 | 492 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2016 | 295 | 0.120 |
Why?
|
| Clinical Laboratory Services | 1 | 2014 | 5 | 0.120 |
Why?
|
| DNA Mutational Analysis | 2 | 2015 | 195 | 0.110 |
Why?
|
| Risk Factors | 6 | 2021 | 4999 | 0.110 |
Why?
|
| Genetic Variation | 3 | 2014 | 367 | 0.110 |
Why?
|
| Genetic Vectors | 1 | 2019 | 813 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2019 | 617 | 0.110 |
Why?
|
| Protein Conformation | 2 | 2015 | 766 | 0.110 |
Why?
|
| Dependovirus | 1 | 2019 | 655 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 285 | 0.110 |
Why?
|
| Ribonucleases | 1 | 2012 | 31 | 0.100 |
Why?
|
| Gene Frequency | 4 | 2014 | 131 | 0.100 |
Why?
|
| Linkage Disequilibrium | 2 | 2012 | 49 | 0.100 |
Why?
|
| Jews | 1 | 2012 | 14 | 0.100 |
Why?
|
| Growth Cones | 1 | 2012 | 14 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2012 | 24 | 0.100 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 1977 | 0.100 |
Why?
|
| Introns | 1 | 2013 | 106 | 0.100 |
Why?
|
| Autophagy | 1 | 2015 | 205 | 0.100 |
Why?
|
| Founder Effect | 1 | 2012 | 11 | 0.100 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2012 | 3 | 0.100 |
Why?
|
| Transcription Factor TFIIIA | 3 | 2018 | 6 | 0.100 |
Why?
|
| Point Mutation | 1 | 2012 | 162 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2012 | 59 | 0.100 |
Why?
|
| Ubiquitination | 1 | 2012 | 106 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 102 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2014 | 2103 | 0.100 |
Why?
|
| Distal Myopathies | 1 | 2011 | 4 | 0.100 |
Why?
|
| Contractile Proteins | 1 | 2011 | 14 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2011 | 9 | 0.090 |
Why?
|
| Membrane Transport Proteins | 3 | 2018 | 119 | 0.090 |
Why?
|
| Protein Domains | 2 | 2024 | 141 | 0.090 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 208 | 0.090 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2010 | 10 | 0.090 |
Why?
|
| Cholesterol | 2 | 2022 | 255 | 0.090 |
Why?
|
| Potassium Channels | 1 | 2010 | 53 | 0.090 |
Why?
|
| Multifunctional Enzymes | 1 | 2010 | 17 | 0.090 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2010 | 11 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2018 | 1456 | 0.090 |
Why?
|
| Primary Cell Culture | 2 | 2020 | 75 | 0.080 |
Why?
|
| Cell Cycle Proteins | 3 | 2018 | 375 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 193 | 0.080 |
Why?
|
| RNA Helicases | 1 | 2010 | 88 | 0.080 |
Why?
|
| Gene Ontology | 2 | 2021 | 37 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2009 | 106 | 0.080 |
Why?
|
| United States | 6 | 2023 | 7495 | 0.080 |
Why?
|
| Heterozygote | 2 | 2022 | 168 | 0.080 |
Why?
|
| Gene Dosage | 2 | 2021 | 60 | 0.080 |
Why?
|
| RNA Splicing | 1 | 2010 | 161 | 0.080 |
Why?
|
| Family | 1 | 2010 | 219 | 0.080 |
Why?
|
| Multigene Family | 1 | 2008 | 93 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2008 | 133 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2012 | 1125 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2010 | 187 | 0.080 |
Why?
|
| Protein Binding | 3 | 2018 | 1551 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 1221 | 0.070 |
Why?
|
| Optic Nerve | 2 | 2020 | 28 | 0.070 |
Why?
|
| Europe | 3 | 2012 | 182 | 0.070 |
Why?
|
| Mass Screening | 1 | 2012 | 646 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 851 | 0.070 |
Why?
|
| Microsatellite Repeats | 2 | 2021 | 37 | 0.070 |
Why?
|
| Adolescent | 4 | 2021 | 5918 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2021 | 1838 | 0.060 |
Why?
|
| United Kingdom | 2 | 2020 | 69 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 847 | 0.060 |
Why?
|
| Protein Aggregation, Pathological | 2 | 2016 | 17 | 0.060 |
Why?
|
| Models, Biological | 1 | 2010 | 1140 | 0.060 |
Why?
|
| Sequestosome-1 Protein | 2 | 2015 | 8 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 387 | 0.060 |
Why?
|
| Internationality | 2 | 2018 | 42 | 0.060 |
Why?
|
| Riluzole | 1 | 2024 | 7 | 0.060 |
Why?
|
| Protein Folding | 2 | 2017 | 256 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1370 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2018 | 663 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 1549 | 0.050 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 1448 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2018 | 861 | 0.050 |
Why?
|
| Gene-Environment Interaction | 1 | 2023 | 50 | 0.050 |
Why?
|
| Glucosylceramidase | 1 | 2022 | 39 | 0.050 |
Why?
|
| Microtubules | 1 | 2023 | 211 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 14 | 0.050 |
Why?
|
| Quality Control | 1 | 2022 | 70 | 0.050 |
Why?
|
| Homozygote | 1 | 2022 | 117 | 0.050 |
Why?
|
| Genomics | 1 | 2024 | 314 | 0.050 |
Why?
|
| Zebrafish | 2 | 2019 | 323 | 0.050 |
Why?
|
| Comorbidity | 2 | 2016 | 1086 | 0.050 |
Why?
|
| Myoclonic Cerebellar Dyssynergia | 1 | 2021 | 1 | 0.050 |
Why?
|
| Rigor Mortis | 1 | 2021 | 1 | 0.050 |
Why?
|
| Glutamine | 1 | 2021 | 47 | 0.050 |
Why?
|
| Muscle Hypotonia | 1 | 2021 | 6 | 0.050 |
Why?
|
| Lysosomes | 1 | 2022 | 162 | 0.050 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2021 | 6 | 0.050 |
Why?
|
| Microglia | 1 | 2024 | 227 | 0.050 |
Why?
|
| Polymorphism, Genetic | 2 | 2012 | 197 | 0.040 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2020 | 3 | 0.040 |
Why?
|
| Rats | 2 | 2016 | 1907 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2012 | 500 | 0.040 |
Why?
|
| Penetrance | 1 | 2020 | 11 | 0.040 |
Why?
|
| Trabeculectomy | 1 | 2020 | 9 | 0.040 |
Why?
|
| Autophagosomes | 1 | 2020 | 11 | 0.040 |
Why?
|
| Ether-A-Go-Go Potassium Channels | 1 | 2019 | 7 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 22 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2022 | 275 | 0.040 |
Why?
|
| Acrylamides | 1 | 2019 | 14 | 0.040 |
Why?
|
| Thiazolidines | 1 | 2019 | 15 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 116 | 0.040 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2019 | 20 | 0.040 |
Why?
|
| Coat Protein Complex I | 1 | 2019 | 5 | 0.040 |
Why?
|
| Arsenites | 1 | 2019 | 7 | 0.040 |
Why?
|
| Cytoplasmic Granules | 1 | 2019 | 53 | 0.040 |
Why?
|
| Dipeptides | 1 | 2019 | 62 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 138 | 0.040 |
Why?
|
| Species Specificity | 1 | 2019 | 336 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 243 | 0.040 |
Why?
|
| Child | 2 | 2021 | 4300 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2019 | 195 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 351 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2019 | 161 | 0.040 |
Why?
|
| Protein Multimerization | 1 | 2019 | 167 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 172 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2019 | 120 | 0.040 |
Why?
|
| Transfection | 1 | 2020 | 673 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2018 | 51 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2022 | 325 | 0.040 |
Why?
|
| Cholinergic Neurons | 1 | 2018 | 9 | 0.040 |
Why?
|
| Wings, Animal | 1 | 2018 | 19 | 0.040 |
Why?
|
| Genome, Human | 2 | 2010 | 219 | 0.040 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2018 | 91 | 0.040 |
Why?
|
| Biopsy | 1 | 2019 | 373 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2019 | 273 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 253 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 150 | 0.040 |
Why?
|
| Armadillo Domain Proteins | 1 | 2018 | 20 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2020 | 461 | 0.040 |
Why?
|
| Gene Editing | 1 | 2022 | 289 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2020 | 772 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2019 | 369 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2017 | 19 | 0.040 |
Why?
|
| S100 Calcium Binding Protein A6 | 1 | 2017 | 3 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2017 | 33 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 252 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 2018 | 95 | 0.040 |
Why?
|
| Gene Transfer Techniques | 1 | 2019 | 304 | 0.040 |
Why?
|
| Decapodiformes | 1 | 2017 | 14 | 0.040 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 71 | 0.040 |
Why?
|
| Cell Survival | 1 | 2019 | 553 | 0.030 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2017 | 33 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 82 | 0.030 |
Why?
|
| Paralysis | 1 | 2016 | 17 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 253 | 0.030 |
Why?
|
| Muscular Atrophy | 1 | 2016 | 26 | 0.030 |
Why?
|
| Skin | 1 | 2019 | 351 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2016 | 26 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2016 | 68 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2016 | 140 | 0.030 |
Why?
|
| Family Health | 1 | 2016 | 68 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 139 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 394 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 201 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 376 | 0.030 |
Why?
|
| Protein Deglycase DJ-1 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Turkey | 1 | 2015 | 13 | 0.030 |
Why?
|
| Autophagy-Related Proteins | 1 | 2015 | 13 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2016 | 294 | 0.030 |
Why?
|
| Computational Biology | 1 | 2017 | 325 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1252 | 0.030 |
Why?
|
| Peptides | 1 | 2018 | 549 | 0.030 |
Why?
|
| TRPM Cation Channels | 1 | 2015 | 15 | 0.030 |
Why?
|
| Ubiquitins | 1 | 2015 | 41 | 0.030 |
Why?
|
| Genes | 1 | 2015 | 96 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2016 | 214 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2015 | 41 | 0.030 |
Why?
|
| Optic Disk | 1 | 2014 | 24 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 672 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2015 | 60 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 846 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 810 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2014 | 190 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 371 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 422 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 480 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 525 | 0.030 |
Why?
|
| Sweden | 1 | 2012 | 41 | 0.030 |
Why?
|
| Germany | 1 | 2012 | 51 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 324 | 0.030 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2012 | 2 | 0.030 |
Why?
|
| HapMap Project | 1 | 2012 | 5 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 215 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 959 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2012 | 75 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 291 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2012 | 53 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1232 | 0.020 |
Why?
|
| Apoptosis | 1 | 2017 | 1038 | 0.020 |
Why?
|
| Registries | 1 | 2015 | 802 | 0.020 |
Why?
|
| Filamins | 1 | 2011 | 7 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2011 | 13 | 0.020 |
Why?
|
| Italy | 1 | 2011 | 62 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 1518 | 0.020 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2010 | 9 | 0.020 |
Why?
|
| Retina | 1 | 2011 | 118 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2009 | 14 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 1312 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2324 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 17 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2009 | 52 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2009 | 158 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2009 | 250 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2009 | 171 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2015 | 1907 | 0.020 |
Why?
|